Model-based Dose-proportionality Testing
Model-Based Dose-Proportionality Testing is a statistical methodology within pharmacokinetic analysis that uses formal mathematical models to characterize the relationship between dose and systemic exposure, distinguishing itself by explicitly modeling dose-proportionality as a function of dose levels through parametric estimation and hypothesis testing.
2
Publications
618
Citations
8
Authors
7
Institutions
Publications per year
2017–2026
0
2
1–2 of 2
8
1
h-index
1
h-index
1
h-index
1
h-index
1
h-index
1–5 of 8
7
Novadip (Belgium)
Mont-Saint-Guibert, Belgium
1 h-index
1 publications
352 citations
Indiana University School of Medicine
Indianapolis, United States
1 h-index
2 publications
704 citations
Eli Lilly (United States)
Indianapolis, United States
1 h-index
2 publications
704 citations
South Warwickshire NHS Foundation Trust
Warwick, United Kingdom
1 h-index
1 publications
266 citations
Indiana University – Purdue University Indianapolis
Indianapolis, United States
1 h-index
3 publications
1.1K citations
AstraZeneca (United Kingdom)
Cambridge, United Kingdom
1 h-index
2 publications
532 citations
Napp Pharmaceuticals (United Kingdom)
Cambridge, United Kingdom
1 h-index
1 publications
266 citations
1–7 of 7
1 publications · 352 citations
1
h-index
DIA · 1 publications · 266 citations
1
h-index
1–2